| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$71 |
Investor Presentation
|
31 Jan 2025 8:24AM |
$0.055 |
$0.035 |
fallen by
36.36%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:24AM |
$0.061 |
$0.070 |
risen by
14.75%
|
|
AER - Price-sensitive ASX Announcement
Full Release
Key Points
- Total receipts of $1,498,540
- Cash and cash equivalents at $1.53 million
- 22% increase in annual recurring revenue
- New contract wins in mining, logistics, insurance, and renewables
- Focus on future developments and service offerings
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$19 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jan 2025 8:24AM |
$0.062 |
$0.045 |
fallen by
27.42%
|
|
QML - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed large initial drilling program at Develin Creek comprising 43 holes for 5,064 meters drilled.
- Significant intersections include 31m @ 2.35% Cu and 17m @ 2.88% Cu from Scorpion deposit.
- Acquired 100% interest in Develin Creek copper project from Zenith Minerals Limited.
- Drilled at Scorpion and Window deposits with results demonstrating potential for resource growth.
- Drilling program completed before Queensland's wet season.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$86,645 |
Update - Notification of buy-back - ANZ
|
31 Jan 2025 8:24AM |
$30.670 |
$29.160 |
fallen by
4.92%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$8,469 |
Leadership Changes and Strategic Realignment
|
31 Jan 2025 8:24AM |
$33.910 |
$36.690 |
risen by
8.20%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Ramsay Health Care announced leadership changes and strategic realignment.
- CFO Martyn Roberts resigned; CEO Carmel Monaghan plans to retire in mid-2025.
- New operational structure to strengthen focus on core Australian hospital business.
- Creation of Chief Operating Officer and Chief Commercial Officer positions in Australia.
- Objective to enhance patient care and improve shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$8 |
FY25 Q2 Quarterly Report and Appendix 5B
|
31 Jan 2025 8:24AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue of $1.5 million, up 105% from the previous quarter.
- Total production of 0.12 PJe, a 90% increase from the prior quarter.
- Cash balance at $2.19 million as of December 31, 2024.
- Merger proposal with Galilee Energy was terminated.
- Restructuring plan to reduce staff headcount and costs by 41%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$62 |
Release of Securities from Mandatory Escrow
|
31 Jan 2025 8:24AM |
$1.640 |
$1.500 |
fallen by
8.54%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$83 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jan 2025 8:24AM |
$0.028 |
$0.045 |
risen by
60.71%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- PainChek submitted FDA De Novo request with clearance expected by May 2025.
- Cumulative PainChek assessments reached 8.69 million, an increase of 111% year-on-year.
- Recognized revenue for six months to December 2024 is $1,658,000, a 27% increase over the prior year.
- PainChek has 100,000 contracted licenses globally with an ARR of $4.8 million.
- First significant home care sale with Anglicare SA for 2100 licenses.
- Raised $5.1 million through a fully underwritten rights issue in December 2024.
- Customer retention rates remain steady at 85%-90% over the past year.
- Positive results from the Infant App Early Access Programme, now available on Apple App Store.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$71 |
Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr
|
31 Jan 2025 8:24AM |
$0.055 |
$0.035 |
fallen by
36.36%
|
|
IPD - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of A$3.3m compared to A$2.7m in Q1 FY25.
- Record cash receipts of A$3.4m, a significant increase from A$2.7m in Q1 FY25.
- Net operating cash outflows reduced to A$2.5 million from A$4.8 million in Q1 FY25.
- Total cash balance is A$17.7 million.
- Annual Recurring Revenue increased to A$12.5 million from A$11.6 million in Q1 FY25.
- Reimbursed covered lives rose to 258.5 million from 146.6 million in Q1 FY25.
- 25 states achieved over 80% reimbursement coverage, up from 16 states in Q1 FY25.
- Opportunity pipeline increased by 112% year-over-year to 622 units.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evolution Mining Limited (EVN) ORDINARY FULLY PAID |
Materials |
$15,599 |
FY25 Half Year Results Conference Call Notification
|
31 Jan 2025 8:24AM |
$5.650 |
$7.790 |
risen by
37.88%
|
|
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$36 |
Update - Notification of buy-back - TEK
|
31 Jan 2025 8:24AM |
$0.135 |
$0.095 |
fallen by
29.63%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,216 |
Investor Conference Call Details for FY25 Half Year Results
|
31 Jan 2025 8:24AM |
$15.670 |
$14.240 |
fallen by
9.13%
|
|
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$8 |
Alternate Director Appointed
|
31 Jan 2025 8:24AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$92 |
Optiscan receives $1.775m R&D Tax Refund
|
31 Jan 2025 8:23AM |
$0.160 |
$0.110 |
fallen by
31.25%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan received a $1,775,733 R&D tax refund for FY24.
- The refund is part of the Australian Federal Government’s R&D tax incentive program.
- The amount is significantly higher than the prior year's $672,320 refund.
- The increase is due to the successful Advance and Overseas Finding application.
- The funds will support ongoing R&D projects at Optiscan.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Birddog Technology Limited (BDT) ORDINARY FULLY PAID |
Information Technology |
$11 |
BDT December 2024 Quarterly Activities Report & Appendix 4C
|
31 Jan 2025 8:23AM |
$0.056 |
$0.068 |
risen by
21.43%
|
|
BDT - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed launch of the first four next-generation products.
- Revised average selling price up by 20% while maintaining net operating margins above 40%.
- Significant improvement in product quality reducing returns.
- Strategically positioned $2 million of inventory in the US.
- Strong cash balance of A$9.7 million as of December 31, 2024.
- Focus on growing US sales with more product launches planned.
- Revenue decline of 13% compared to the previous year.
- Net cash outflow from operations impacted by insurance payments.
- Appointment of Mr. Peter Cooke as a Non-executive Director.
- Webinar planned to discuss strategic imperatives and milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$62 |
Q2 FY25 Quarterly Activities Report and Appendix 4C
|
31 Jan 2025 8:23AM |
$1.640 |
$1.500 |
fallen by
8.54%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful IPO raised $35 million to fund growth.
- Customer validation studies in animal and human health are progressing well.
- North American expansion efforts are underway with recruitment of expertise.
- Product development projects, including Vitrafy Cryopreservation Unit 2.0 and LifeChain software, are on schedule.
- The company has a cash position of approximately $34.4 million for future initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$1,824 |
Net Tangible Asset Backing
|
31 Jan 2025 8:23AM |
$2.860 |
$2.900 |
risen by
1.40%
|
|
| Apollo Minerals Limited (AON) ORDINARY FULLY PAID |
Materials |
$6 |
December 2024 Quarterly Report
|
31 Jan 2025 8:23AM |
$0.014 |
$0.007 |
fallen by
50%
|
|
AON - Price-sensitive ASX Announcement
Full Release
Key Points
- Apollo Minerals Limited presents its quarterly report for the period ending 31 December 2024.
- The report highlights exploration activities at the Salanie Gold Project in Gabon.
- Initial drilling returned exceptional results indicating high-grade gold potential.
- A1 Prospect drilling yielded 11.7m at 4.3g/t Au.
- Drilling at P6 showed gold anomalism along historical workings.
- Capital Drilling engaged for increased productivity in upcoming drilling phases.
- The company raised approximately $1.25 million from a previously announced entitlement offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AUB Group Limited (AUB) ORDINARY FULLY PAID |
Financials |
$4,137 |
AUB Key Investor Dates 2025
|
31 Jan 2025 8:23AM |
$31.600 |
$35.480 |
risen by
12.28%
|
|
| Frontier Digital Ventures Limited (FDV) ORDINARY FULLY PAID |
Communication Services |
$91 |
4Q 2024 Trading Update
|
31 Jan 2025 8:23AM |
$0.260 |
$0.210 |
fallen by
19.23%
|
|
FDV - Price-sensitive ASX Announcement
Full Release
Key Points
- 4Q 2024 operating revenue of A$20.0m.
- 4Q 2024 operating EBITDA of A$1.6m.
- FDV Asia revenue grew by 41% year-over-year.
- 360 LATAM revenue declined by 18% year-over-year.
- MENA Marketplaces Group achieved record revenue of A$2.9m in 4Q 2024.
- Focus on expanding higher-margin products and subscription services.
- Strategic review initiated to maximize shareholder value.
- Targeting positive free cash flow in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$8 |
Entitlement offer with options to fund Production Uplift Pro
|
31 Jan 2025 8:23AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Entitlement Offer to raise $2.1 million to fund substantial production uplift
- Entitlement Offer of 1 for 4 at 0.5 cents per share
- Every New Share issued under entitlement offer to be accompanied by 1 free attaching option
- Production uplift program targeting near term returns for uplift in flow rates and cash generation
- Increased gas production expected from Odin and Vali gas fields
- Initial measures at Odin-1 increased gas production significantly
- Funds will be used for scale management and investigation operations
- Immediate increase in gas flows anticipated to Pelican Point Power and AGL contracts
- Eligible shareholders will receive a personalized entitlement and acceptance form
- Investor presentation has been lodged with the ASX for further information
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$57,666 |
ResMed Announces Results for the Second Quarter of FY2025
|
31 Jan 2025 8:22AM |
$40.500 |
$39.350 |
fallen by
2.84%
|
|
RMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 10% to $1.3 billion.
- Gross margin improved 300 bps to 58.6%.
- Operating profit increased by 52% year-over-year.
- Diluted earnings per share rose to $2.34.
- Operating cash flow for the quarter was $309 million.
- ResMed launched the Kontor Head Strap accessory for Apple Vision Pro.
- The company reaffirmed commitment to expand operations in Singapore.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$19 |
Retirement of Independent Director & New Board Appointment
|
31 Jan 2025 8:22AM |
$0.380 |
$0.255 |
fallen by
32.89%
|
|
| New Frontier Minerals Limited (NFM) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Cash Flow and Activities Report - December 2024
|
31 Jan 2025 8:22AM |
$0.017 |
$0.009 |
fallen by
47.06%
|
|
NFM - Price-sensitive ASX Announcement
Full Release
Key Points
- Divestment of the Cangai Copper Mine Project completed.
- Acquired the Harts Range Project with high-grade niobium and uranium.
- Company rebranded to New Frontier Minerals Limited.
- Quarterly cash and liquid investments totalled $1.569 million.
- Surface sampling at the Big One Deposit confirmed high-grade copper.
- A heliborne survey is scheduled for January 2025 to identify uranium and critical mineral targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Weebit Nano Ltd (WBT) ORDINARY FULLY PAID |
Information Technology |
$338 |
Weebit Nano Q2 FY25 Activities Report and Appendix 4C
|
31 Jan 2025 8:22AM |
$2.320 |
$1.625 |
fallen by
29.96%
|
|
WBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Weebit signed a major licensing agreement with onsemi.
- The company raised A$50 million at a premium to strengthen its balance sheet.
- Qualification of ReRAM technology at DB HiTek is in progress.
- Weebit has a cash balance of A$97 million as of 31 December 2024.
- Four new patents were granted related to ReRAM technology.
- Anne Templeman-Jones was appointed as Non-Executive Director.
- Participation in CES and ICCAD 2024 showcased Weebit's technological advancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
